Latest News about BGNE
Recent news which mentions BGNE
Why Summit Therapeutics Rocketed Double-Digits Today
April 23, 2025
From Motley Fool
Super Micro Computer, Adobe And Nucor Are Among Top Large Cap Losers Last Week (December 9-13): Are The Others In Your Portfolio?
December 15, 2024
From Benzinga
A Glimpse Into The Expert Outlook On BeiGene Through 4 Analysts
December 03, 2024
Tickers
BGNE
From Benzinga
Why Is BeiGene Stock Trading Higher On Wednesday?
November 27, 2024
From Benzinga
From Benzinga
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
September 25, 2024
From Benzinga
Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug
September 18, 2024
From Benzinga
Oxford Industries Reports Weak Results, Joins Viper Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
September 12, 2024
From Benzinga
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
September 12, 2024
From Benzinga
Innovent Bio hopes for plus-sized profits from obesity drug
September 06, 2024
From Benzinga
Top 2 Health Care Stocks That May Plunge In August
August 26, 2024
From Benzinga
Cancer Medicines From Merck, Bristol Myers And BeiGene In Question, As FDA Committee To Discuss Limiting PD-1 Drugs For Stomach Cancer
August 23, 2024
From Benzinga
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
July 22, 2024
From Motley Fool
From Benzinga
From Benzinga
7 Large-Cap Stocks That Can Jump 50% By 2025
May 29, 2024
From InvestorPlace
From Benzinga
Tickers
BGNE
From InvestorPlace
Tracking Last Week's Top Performers: Are These 15 Large-Cap Stocks In Your Portfolio? (April 21-27, 2024)
April 28, 2024
From Benzinga
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
April 23, 2024
From Benzinga
Lululemon Issues Weak Outlook, Joins Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session
March 22, 2024
From Benzinga
FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer
March 15, 2024
From Benzinga
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 13, 2024
From Benzinga
Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
March 13, 2024
From Benzinga
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
March 08, 2024
From Benzinga
Hang Seng Index Set For Global Expansion With Prada, XPeng, And BeiGene On The Horizon
February 16, 2024
From Benzinga